SUBSCRIBE
SUBSCRIBE

Patient recruitment

PRESS RELEASES
Press Releases
SELLAS Life Sciences Announces First Pediatric AML Patient Dosed in the Ongoing Phase 2 Trial of SLS009 r/r AML
May 16, 2025
 · 
4 min read
Press Releases
BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
May 15, 2025
 · 
9 min read
Press Releases
START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors
May 15, 2025
 · 
2 min read
Press Releases
AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London
May 15, 2025
 · 
6 min read
Press Releases
EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy, with international trial site in Singapore to follow
May 13, 2025
 · 
3 min read
Press Releases
GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
May 7, 2025
 · 
8 min read
Press Releases
BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study
May 7, 2025
 · 
4 min read
Press Releases
BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
May 7, 2025
 · 
4 min read
Press Releases
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration
May 2, 2025
 · 
5 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy
May 2, 2025
 · 
3 min read
Press Releases
Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment
May 1, 2025
 · 
5 min read
Press Releases
Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas
May 1, 2025
 · 
4 min read
Press Releases
Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 from its Phase 1 Trial of PAS-004 in Advanced Cancer Patients
April 30, 2025
 · 
3 min read
Press Releases
Alcresta Therapeutics Announces Enrollment of First Patient in Clinical Trial Evaluating Use of RELiZORB in Pancreatitis Patients at Massachusetts General Hospital
April 30, 2025
 · 
3 min read
Press Releases
Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST
April 29, 2025
 · 
8 min read
Press Releases
Levee Medical® Announces First Patient Enrolled in ARID II IDE Pivotal Trial
April 25, 2025
 · 
1 min read
Press Releases
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes
April 24, 2025
 · 
8 min read
Press Releases
March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First-in-Class CD5 CAR-T Cell Therapy for T-Cell Lymphoma
April 23, 2025
 · 
4 min read
Press Releases
Carthera Reaches Recruitment Milestone in SONOBIRD Pivotal Trial for Recurrent Glioblastoma
April 22, 2025
 · 
5 min read
Press Releases
OM1 Adds 1 Million Patients to Its Mental Health Network, Significantly Expanding Specialty Coverage and Driving New Possibilities for Real-World Research and Personalized Care
April 22, 2025
 · 
2 min read
Load More